ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,683.20
-1.82%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.4235
0.18%
Brent Oil
83.245
-1.30%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CytomX Therapeutics Inc (CTMX)

  7. CytomX Therapeutics Inc (CTMX) ニュース

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTMX
日付受信時刻ニュースソース見出しコード企業名
2021/02/2506 : 15GlobeNewswire Inc.CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/2222 : 00GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming March Virtual Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/1922 : 00GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/1722 : 00GlobeNewswire Inc.CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021NASDAQ:CTMXCytomX Therapeutics Inc
2021/02/1207 : 28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
2021/02/1100 : 50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
2021/02/0422 : 00GlobeNewswire Inc.CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology DayNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/0322 : 18GlobeNewswire Inc.UPDATE - CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/0322 : 00GlobeNewswire Inc.CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CTMXCytomX Therapeutics Inc
2021/02/0305 : 22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
2021/01/3006 : 31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
2021/01/3000 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
2021/01/2622 : 00GlobeNewswire Inc.CytomX Therapeutics Announces Closing of Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
2021/01/2207 : 05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
2021/01/2111 : 50GlobeNewswire Inc.CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
2021/01/2007 : 13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
2021/01/2006 : 35GlobeNewswire Inc.CytomX Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
2021/01/1922 : 00GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantsNASDAQ:CTMXCytomX Therapeutics Inc
2021/01/0722 : 00GlobeNewswire Inc.CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
2020/12/2907 : 16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/2306 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/2306 : 05GlobeNewswire Inc.CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
2020/12/1906 : 42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/1906 : 41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/0807 : 00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/0806 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/0806 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/12/0322 : 00GlobeNewswire Inc.CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer SymposiumNASDAQ:CTMXCytomX Therapeutics Inc
2020/11/1206 : 01GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
2020/11/1106 : 59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

最近閲覧した銘柄

CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
CCOM
US30
US 30
SPI
SP500
S&P 500
NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有